Neuberger Berman Group
ISEE

Neuberger Berman Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Neuberger Berman Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-42,896
Closed -$1.04M – 1905
2023
Q1 		$1.04M Buy
+42,896
New +$939K ﹤0.01% 1239
2016
Q4 		– Sell
-4,500
Closed -$208K – 1661
2016
Q3 		$208K Sell
4,500
-15,500
-78% -$874K ﹤0.01% 1509
2016
Q2 		$1.02M Buy
+20,000
New +$994K ﹤0.01% 1095
2014
Q4 		– Sell
-16,554
Closed -$644K – 1706
2014
Q3 		$644K Sell
16,554
-1,846
-10% -$72.5K ﹤0.01% 1326
2014
Q2 		$779K Buy
+18,400
New +$675K ﹤0.01% 1298

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Neuberger Berman Group's ISEE Position: Q2 2023 in Review

Neuberger Berman Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 42,896 shares — an estimated $1.04M sold.

Neuberger Berman Group first reported a position in ISEE in Q2 2014 and held it in 5 quarters. The position peaked at $1.04M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Neuberger Berman Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Neuberger Berman Group sold 42,896 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $1.04M.
  • Neuberger Berman Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 5 quarters.
  • Neuberger Berman Group's IVERIC bio, Inc. Common Stock position peaked at $1.04M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Neuberger Berman Group's 13F filing for Q2 2023, filed 11 Aug 2023.